MultiPlan Co. (NYSE:MPLN - Get Free Report) saw a significant drop in short interest in December. As of December 15th, there was short interest totalling 302,600 shares, a drop of 13.7% from the November 30th total of 350,700 shares. Approximately 4.6% of the shares of the company are short sold. Based on an average trading volume of 112,900 shares, the days-to-cover ratio is currently 2.7 days.
MultiPlan Stock Performance
Shares of MultiPlan stock traded down $2.06 on Monday, hitting $15.46. The company's stock had a trading volume of 258,797 shares, compared to its average volume of 79,852. The firm has a market cap of $250.00 million, a P/E ratio of -0.16 and a beta of 0.42. MultiPlan has a 1 year low of $4.80 and a 1 year high of $58.40. The company has a quick ratio of 1.05, a current ratio of 1.05 and a debt-to-equity ratio of 21.73. The firm's fifty day moving average is $8.30.
Institutional Trading of MultiPlan
A number of institutional investors and hedge funds have recently made changes to their positions in MPLN. Millennium Management LLC increased its stake in shares of MultiPlan by 3,401.0% during the second quarter. Millennium Management LLC now owns 8,426,081 shares of the company's stock worth $3,273,000 after purchasing an additional 8,185,402 shares in the last quarter. AQR Capital Management LLC increased its stake in MultiPlan by 386.2% during the 2nd quarter. AQR Capital Management LLC now owns 2,742,735 shares of the company's stock worth $1,065,000 after buying an additional 2,178,590 shares in the last quarter. Point72 Asia Singapore Pte. Ltd. acquired a new position in shares of MultiPlan during the second quarter valued at approximately $245,000. Hsbc Holdings PLC lifted its position in shares of MultiPlan by 68.7% in the second quarter. Hsbc Holdings PLC now owns 218,459 shares of the company's stock valued at $87,000 after acquiring an additional 88,944 shares in the last quarter. Finally, Cubist Systematic Strategies LLC acquired a new stake in shares of MultiPlan in the second quarter worth approximately $72,000. 87.15% of the stock is currently owned by hedge funds and other institutional investors.
Wall Street Analysts Forecast Growth
Separately, Citigroup decreased their target price on shares of MultiPlan from $17.20 to $10.00 and set a "neutral" rating for the company in a research note on Monday, September 23rd.
Check Out Our Latest Report on MPLN
About MultiPlan
(
Get Free Report)
MultiPlan Corporation, together with its subsidiaries, provides data analytics and technology-enabled cost management, payment, and revenue integrity solutions to the healthcare industry in the United States. The company offers analytics-based services that reduce medical costs, through data-driven algorithms and insights that detect claims over-charges and negotiate or recommend reimbursement; and network-based services that provide contracted discounts with healthcare providers, as well as outsourced network development and management services.
Featured Articles
Before you consider MultiPlan, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and MultiPlan wasn't on the list.
While MultiPlan currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.